Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis

Completed · Not applicable

Conditions studied: Cardiac Amyloidosis

In brief

The purpose of this study is to assess a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis of cardiac amyloidosis (CA).

Key facts

Study ID

NCT05557162

Run by

Mayo Clinic

People needed

20143

Starts

2023-06-19

Expected to finish

2025-07-23

Last updated by the study team

2026-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Mayo Clinic cardiology or hematology providers who care for adult patients
• Mayo Clinic providers who consent to participate on this study

You may not qualify if…

• None

Where it is running

• Mayo Clinic in Arizona — Scottsdale, Arizona, United States
• Mayo Clinic in Florida — Jacksonville, Florida, United States
• Mayo Clinic in Rochester — Rochester, Minnesota, United States
• Mayo Clinic Health System - Eau Claire — Eau Claire, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.